Novel Long Non-coding RNA for the Treatment of Colorectal Cancer

by Clarissa | Apr 28, 2026 | Cabanski, Christopher, Fields, Ryan, Maher, Christopher, Ryan, Silva-Fisher, Jessica

Publication date: 4/28/2026 Value Proposition: Non-coding RNA as a novel biomarker and therapeutic target for treating colon cancer. Technology Description Researchers at Washington University in St. Louis have developed a novel non-coding RNA, named RAMS11, as a...

Therapy Method that Uses Long Non-Coding RNA and CDK4/6 Inhibitors to Treat Breast Cancer

by | Apr 20, 2026 | Mishra, Richa, Silva-Fisher, Jessica

— Published date: 4/18/2026

Value Proposition: Combination cancer therapy that utilizes long non-coding RNA and CDK4/6 inhibitors to treat breast cancer.

Technology Description

Researchers at Washington University in St. Louis have developed a cancer combination therapy using CDK4/6 inhibitors an…

New Process for Treating Multiple Myeloma

by | Dec 13, 2024 | Silva-Fisher, Jessica

— Value Proposition: Long non-coding RNA as biomarker and therapeutic target for treating diagnosed multiple myeloma patients.

Technology Description

Researchers at Washington University in St. Louis have developed a long non-coding RNA as a diagnostic marker and clinical target for multiple my…

Long non-coding RNA as cancer biomarker and drug target

by | Nov 12, 2021 | Cabanski, Christopher, Fields, Ryan, Maher, Christopher, Silva-Fisher, Jessica

— Technology Description

Researchers in Prof. Christopher Maher’s research program (in conjunction with collaborator Ryan Fields) discovered that RAMS11 (RNA Associated with Metastasis 11), a novel long non-coding RNA, (i) promotes metastatic disease, (ii) confers resistance to topoisomerase i…